Human medicines European public assessment report (EPAR): Vfend, voriconazole, Candidiasis;Mycoses;Aspergillosis, Date of authorisation: 19/03/2002, Revision: 55, Status: Authorised

Marketing authorisation (veterinary medicines)

Referral procedures: veterinary medicines

Veterinary limited markets

Questions and answers on data requirements when transitioning to low global warming potential (LGWP) propellants in oral pressurised metered dose inhalers

Questions and answers on data requirements when replacing hydrofluorocarbons as propellants in oral pressurised metered dose inhalers

Academia

Human medicines European public assessment report (EPAR): Nuvaxovid, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 20/12/2021, Revision: 11, Status: Authorised

Withdrawn application: Gefzuris, gefapixant, Date of withdrawal: 14/07/2023, Initial authorisation

Human medicines European public assessment report (EPAR): VidPrevtyn Beta, COVID-19 Vaccine (recombinant, adjuvanted), COVID-19 virus infection, Date of authorisation: 10/11/2022, Revision: 1, Status: Authorised